For: | Hijioka S, Chin K, Seto Y, Yamamoto N, Hatake K. Eight-year survival after advanced gastric cancer treated with S-1 followed by surgery. World J Gastroenterol 2010; 16(22): 2824-2827 [PMID: 20533605 DOI: 10.3748/wjg.v16.i22.2824] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v16/i22/2824.htm |
Number | Citing Articles |
1 |
Long Yan, Hongbin Liu, Hongtao Li, Xiaopeng Han, Tingbao Cao, Chaoyang Wang, Gaitian Li. The efficacy and feasibility of adopting intravenous chemotherapy and oral S-1 as a sequential therapy for postoperative gastric cancer patients. Medicine 2019; 98(44): e17605 doi: 10.1097/MD.0000000000017605
|
2 |
En-Yi Liu, Mei-Zuo Zhong, Cai-Gang Liu, Jin Huang, Wei Liu, Shan Zeng, Bin Li, Jing-Chen Lu, Jian-Huang Li, Hai-Rong Jiang. Recurrent patterns and factors involved in node-negative advanced gastric cancer. Chinese Journal of Cancer Research 2010; 22(4): 285 doi: 10.1007/s11670-010-0285-3
|
3 |
I. D. Amelina, L. N. Shevkunov, A. M. Karachun, A. L. Muravtseva, A. S. Artemyeva. Gastric Cancer Imaging: Computed Tomographic Pneumogastrography. Journal of radiology and nuclear medicine 2021; 102(3): 155 doi: 10.20862/0042-4676-2021-102-3-155-165
|
4 |
Jae-Woo Park, Jeungwon Yoon, Chong-Kwan Cho, Yeon-Weol Lee, Hwa-Seung Yoo. Survival analysis of stage IV metastatic gastric cancer patients treated with HangAm-Plus. Chinese Journal of Integrative Medicine 2014; 20(1): 49 doi: 10.1007/s11655-012-1084-0
|
5 |
Silvia Mazzaferro, Kawthar Bouchemal, Gilles Ponchel. Oral delivery of anticancer drugs II: the prodrug strategy. Drug Discovery Today 2013; 18(1-2): 93 doi: 10.1016/j.drudis.2012.08.006
|